DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, DM | ko |
dc.contributor.author | Lee, SJ | ko |
dc.contributor.author | Yoon, SK | ko |
dc.contributor.author | Byun, Si Myung | ko |
dc.date.accessioned | 2013-03-03T23:35:13Z | - |
dc.date.available | 2013-03-03T23:35:13Z | - |
dc.date.created | 2012-02-06 | - |
dc.date.created | 2012-02-06 | - |
dc.date.issued | 2002-01 | - |
dc.identifier.citation | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, v.290, no.1, pp.585 - 588 | - |
dc.identifier.issn | 0006-291X | - |
dc.identifier.uri | http://hdl.handle.net/10203/80937 | - |
dc.description.abstract | Several pathogenic bacteria secrete plasminogen activator proteins. Streptokinase (SKe) produced by Streptococcus equisimilis and staphylokinase secreted from Staphylococcus aureus are human plasminogen activators and streptokinase (SKu), produced by Streptococcus uberis, is a bovine plasminogen activator. Thus, the fusion proteins among these activators can explain the function of each domain of SKe. Replacement of the SKalpha domain with staphylokinase donated the staphylokinase-like activation activity to SKe, and the SKbetagamma, domain played a role of nonproteolytic activation of plasminogen. Recombinant SKu also activated human plasminogen by staphylokinase-like activation mode. Because SKu has homology with SKe, the bovine plasminogen activation activities of SKe fragments were checked. SKebetagamma among them had activation activity with bovine plasminogen. This means that the C-terminal domain (gamma-domain) of streptokinase determines plasminogen species necessary or activation and converses the ability of substrate recognition to human species. (C) 2002 Elsevier Science. | - |
dc.language | English | - |
dc.publisher | ACADEMIC PRESS INC ELSEVIER SCIENCE | - |
dc.subject | STREPTOCOCCUS-UBERIS | - |
dc.subject | THROMBOLYTIC THERAPY | - |
dc.subject | RECOMBINANT STAPHYLOKINASE | - |
dc.subject | BOVINE PLASMINOGEN | - |
dc.subject | ESCHERICHIA-COLI | - |
dc.subject | PURIFICATION | - |
dc.subject | SECRETION | - |
dc.subject | SUBSTRATE | - |
dc.subject | CLEAVAGE | - |
dc.subject | COMPLEX | - |
dc.title | Specificity role of the streptokinase C-terminal domain in plasminogen activation | - |
dc.type | Article | - |
dc.identifier.wosid | 000173480900089 | - |
dc.type.rims | ART | - |
dc.citation.volume | 290 | - |
dc.citation.issue | 1 | - |
dc.citation.beginningpage | 585 | - |
dc.citation.endingpage | 588 | - |
dc.citation.publicationname | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | - |
dc.identifier.doi | 10.1006/bbrc.2001.6238 | - |
dc.contributor.nonIdAuthor | Kim, DM | - |
dc.contributor.nonIdAuthor | Lee, SJ | - |
dc.contributor.nonIdAuthor | Yoon, SK | - |
dc.type.journalArticle | Article | - |
dc.subject.keywordAuthor | streptokinase | - |
dc.subject.keywordAuthor | staphylokinase | - |
dc.subject.keywordAuthor | plasminogen | - |
dc.subject.keywordAuthor | plasmin | - |
dc.subject.keywordAuthor | activation | - |
dc.subject.keywordAuthor | fusion | - |
dc.subject.keywordAuthor | specificity | - |
dc.subject.keywordAuthor | domain | - |
dc.subject.keywordAuthor | alpha(2)-antiplasmin | - |
dc.subject.keywordAuthor | fibrin | - |
dc.subject.keywordPlus | STREPTOCOCCUS-UBERIS | - |
dc.subject.keywordPlus | THROMBOLYTIC THERAPY | - |
dc.subject.keywordPlus | RECOMBINANT STAPHYLOKINASE | - |
dc.subject.keywordPlus | BOVINE PLASMINOGEN | - |
dc.subject.keywordPlus | ESCHERICHIA-COLI | - |
dc.subject.keywordPlus | PURIFICATION | - |
dc.subject.keywordPlus | SECRETION | - |
dc.subject.keywordPlus | SUBSTRATE | - |
dc.subject.keywordPlus | CLEAVAGE | - |
dc.subject.keywordPlus | COMPLEX | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.